Karl Stéfic
- Infectious Diseases top 2%
- Neurology top 2%
- Clinical Psychology top 5%
- Molecular Biology
- Epidemiology
- Co-authors
- Catherine Gaudy‐GraffinLouis BernardLeslie Grammatico‐GuillonÉmeline LaurentAdrien LemaignenF. BruyèreCéline Bourbao-TournoisThomas Flament
- Topics
- HIV Research and Treatment (18 papers)HIV/AIDS Research and Interventions (14 papers)HIV/AIDS drug development and treatment (12 papers)
- Cited by
- Infectious DiseasesNeurologyVirology
- Partner nations
- FranceUnited StatesAustralia
In The Last Decade
Karl Stéfic
30 papers receiving 964 citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Infectious Diseases 619
- Neurology 494
- Clinical Psychology 252
- Molecular Biology 141
- Epidemiology 102
Countries citing papers authored by Karl Stéfic
This map shows the geographic impact of Karl Stéfic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Stéfic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Stéfic more than expected).
Fields of papers citing papers by Karl Stéfic
This network shows the impact of papers produced by Karl Stéfic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Stéfic. The network helps show where Karl Stéfic may publish in the future.
Co-authorship network of co-authors of Karl Stéfic
This figure shows the co-authorship network connecting the top 25 collaborators of Karl Stéfic. A scholar is included among the top collaborators of Karl Stéfic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Stéfic. Karl Stéfic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 21 | |
| 9 | 7 | |
| 10 | 29 | |
| 11 | 5 | |
| 12 | 130 | |
| 13 | 10 | |
| 14 | 92 | |
| 15 | 3 | |
| 16 | Follow-up of adults with noncritical COVID-19 two months after symptom onsetbreakdown → | 513 |
| 17 | 13 | |
| 18 | 0 | |
| 19 | 0 | |
| 20 | 18 |
About Karl Stéfic
Karl Stéfic is a scholar working on Virology, Infectious Diseases and Biological Psychiatry, having authored 34 papers that have together received 994 indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (12 papers). The work is most often cited by research in Infectious Diseases (619 citations), Neurology (494 citations) and Virology (99 citations). Karl Stéfic has collaborated with scholars based in France, United States and Australia. Frequent co-authors include Catherine Gaudy‐Graffin, Louis Bernard, Leslie Grammatico‐Guillon, Émeline Laurent, Adrien Lemaignen, F. Bruyère, Céline Bourbao-Tournois, Thomas Flament, Nicole Ferreira-Maldent and Claudia Carvalho-Schneider. Their work appears in journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.